Ivermectin Treatment Coverage Validation in Two Onchocerciasis Endemic Districts in Ethiopia: A Community-Based Cross-Sectional Study, 2019

BACKGROUND: Onchocerciasis is the second leading cause of blindness globally next to trachoma, thus eliminating the infection is an important health priority. It is estimated that 15.7 million people are at risk of infection in different parts of Ethiopia. Mass drug administration with ivermectin at...

Descripción completa

Detalles Bibliográficos
Autores principales: Churko, Chuchu, Yihune, Manaye, Teshome, Abinet, Chisha, Yilma, Getachew, Birhanu, Sleshi, Markos, Asfaw, Mekuria Asnakew, Shibiru, Tamiru, Ayele, Nebiyu Negussu, Seife, Fikre, Zerdo, Zerihun, Bekele Kassahun, Alemayehu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822083/
https://www.ncbi.nlm.nih.gov/pubmed/33500622
http://dx.doi.org/10.2147/JMDH.S288239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822083/
https://www.ncbi.nlm.nih.gov/pubmed/33500622
http://dx.doi.org/10.2147/JMDH.S288239

Ejemplares similares